Quant Healthcare Fund
Monthly portfolio · 24 months through Sep-2026
compared to Aug-2026 · as on 30 Sep 2026
Holdings
25
Scheme AUM
₹425 cr
New
11
Exited
5
Increased
2
Reduced
3
| Change | Security | Industry / Rating | Quantity | Δ Qty | % to NAV | Δ % | Market value |
|---|---|---|---|---|---|---|---|
| — | Glaxosmithkline Pharmaceuticals Ltd INE159A01016 | N.A. | 1,48,558 | — | 9.69% | -0.89pp | ₹41.14 cr |
| New | Divi's Laboratories Ltd. INE361B01024 | N.A. | 43,800 | — | 9.63% | — | ₹40.89 cr |
| Increased | Aurobindo Pharma Limited INE406A01037 | N.A. | 2,43,572 | +1,14,400 | 9.61% | +4.43pp | ₹40.78 cr |
| — | Zydus Lifesciences Limited INE010B01027 | N.A. | 3,42,900 | — | 9.39% | +0.09pp | ₹39.85 cr |
| New | Glenmark Pharmaceuticals Ltd. INE935A01035 | N.A. | 1,68,000 | — | 9.34% | — | ₹39.64 cr |
| Increased | Strides Pharma Science Ltd INE939A01011 | N.A. | 3,42,537 | +2,40,282 | 9.04% | +6.59pp | ₹38.36 cr |
| New | Torrent Pharmaceuticals Ltd. INE685A01028 | N.A. | 75,750 | — | 8.62% | — | ₹36.6 cr |
| — | Pfizer Ltd INE182A01018 | N.A. | 80,707 | — | 7.37% | -1.46pp | ₹31.28 cr |
| Reduced | Alivus Life Sciences INE03Q201024 | N.A. | 1,91,248 | -55,050 | 6.21% | -1.87pp | ₹26.38 cr |
| Reduced | IPCA Laboratories Ltd INE571A01038 | N.A. | 1,31,743 | -3,092 | 5.98% | -0.24pp | ₹25.39 cr |
| Reduced | Zydus Wellness Ltd INE768C01028 | N.A. | 4,05,376 | -50,442 | 4.90% | -0.75pp | ₹20.79 cr |
| New | Colgate-Palmolive (India) Ltd INE259A01022 | N.A. | 83,050 | — | 3.45% | — | ₹14.64 cr |
| New | Natco Pharma Ltd INE987B01026 | N.A. | 1,54,500 | — | 3.01% | — | ₹12.78 cr |
| New | Dr. Reddy's Laboratories Limited INE089A01031 | N.A. | 80,322 | — | 2.33% | — | ₹9.9 cr |
| — | 91 Days Treasury Bill 15-Oct-2026 IN002026X156 | SOV | 3,00,000 | — | 0.71% | +0.01pp | ₹2.99 cr |
| — | 91 Days Treasury Bill 22-Oct-2026 IN002026X164 | SOV | 3,00,000 | — | 0.70% | +0.01pp | ₹2.99 cr |
| — | 91 Days Treasury Bill 05-Nov-2026 IN002026X180 | SOV | 3,00,000 | — | 0.70% | +0.01pp | ₹2.98 cr |
| — | 91 Days Treasury Bill 19-Nov-2026 IN002026X206 | SOV | 3,00,000 | — | 0.70% | +0.01pp | ₹2.98 cr |
| — | 91 Days Treasury Bill 27-Nov-2026 IN002026X214 | SOV | 3,00,000 | — | 0.70% | +0.01pp | ₹2.98 cr |
| New | 91 Days Treasury Bill 03-Dec-2026 IN002026X222 | SOV | 3,00,000 | — | 0.70% | — | ₹2.97 cr |
| New | 91 Days Treasury Bill 10-Dec-2026 IN002026X230 | SOV | 3,00,000 | — | 0.70% | — | ₹2.97 cr |
| New | 91 Days Treasury Bill 17-Dec-2026 IN002026X248 | SOV | 3,00,000 | — | 0.70% | — | ₹2.97 cr |
| New | 91 Days Treasury Bill 24-Dec-2026 IN002026X255 | SOV | 3,00,000 | — | 0.70% | — | ₹2.96 cr |
| New | LG Electronics India Limited INE324D01010 | N.A. | 14,600 | — | 0.59% | — | ₹2.52 cr |
| — | Heubach Colorants India Limited INE258G01013 | N.A. | 25,514 | — | 0.26% | -0.05pp | ₹1.11 cr |
| Exited | Concord Biotech Limited INE338H01029 | N.A. | — | -2,08,326 | — | -7.03pp | — |
| Exited | SMS Pharmaceuticals Limited INE812G01025 | N.A. | — | -7,72,728 | — | -6.71pp | — |
| Exited | 91 Days Treasury Bill 03-Sep-2026 IN002026X099 | SOV | — | -3,00,000 | — | -0.70pp | — |
| Exited | 91 Days Treasury Bill 10-Sep-2026 IN002026X107 | SOV | — | -3,00,000 | — | -0.70pp | — |
| Exited | 91 Days Treasury Bill 17-Sep-2026 IN002026X115 | SOV | — | -3,00,000 | — | -0.70pp | — |
Cash & other
| TREPS 01-Oct-2026 DEPO 10 | 26.57% | ₹113 cr |
| NCA-NET CURRENT ASSETS | -32.30% | ₹-137.12 cr |